TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ORIFARM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ORIFARM

ST13

US500000079370271

Classe

3, 5, 10, 35

Pedido

79370271

Registro

7885422

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

43

Atualização mais recente

06/03/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

3, 5, 10, 35

Data de depósito

27/01/2023

Data de registro

12/08/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/08/2025

Última transação

06/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

84

Localização do titular

DK

Examinador

SULLIVAN, JOHN C

Unidade examinadora

M50

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

Orifarm Generics A/S

Representantes

Meichelle R. MacGregor Cowan, Liebowitz & Latman, P.C.

Classificação técnica

Classes Nice

Classe 3Classe 5Classe 10Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 3

Non-medicated cosmetics and toiletry preparations, perfumery; essential oils; the foregoing excluding dental and other oral health care products

Classe 5

Pharmaceutical preparations and chemical preparations for medical and veterinary purposes, namely, for the treatment of metabolic and digestive conditions, hematopoietic and circulatory conditions, cardiac health conditions, dermatological conditions, urogenital conditions, sex hormonal conditions, systemic hormonal conditions, infectious diseases, antineoplastic and immunomodulatory conditions, musculoskeletal health conditions, neurological conditions, parasitological conditions, respiratory conditions, ocular and auditory health conditions, allergens-related conditions, hyperkalemia, hyperphosphatemia, calcium metabolic imbalances, and in the nature of pharmaceutical and medical preparations containing vitamins, minerals, antidotes, iron chelating agents, and contrast agents for the treatment of the aforementioned conditions; the foregoing excluding dental and other oral health care products

Classe 10

Surgical apparatus and instruments; medical and veterinary apparatus and instruments for surgical use; medical and veterinary apparatus and instruments for therapeutic use, namely, therapeutic equipment and devices for treating respiratory, metabolic and cardiovascular diseases in the nature of colds, coughing, nasal congestion, sore throat, ear congestion, sinus congestion, sinus inflammation, and inflammatory eye diseases; artificial limbs and eyes; orthopedic articles, namely, cushions, supports, padding, bandages, braces, footwear, hosiery, soles, belts, and walkers; suture materials; therapeutic articles and aids adapted for persons with disabilities, namely, compression wraps; massage apparatus; devices and articles for nursing infants, namely, bottles; devices and articles for sexual activity, namely, sex toys; the foregoing excluding dental equipment and other oral health care products

Classe 35

Retail and wholesale store services featuring non-medicated cosmetics and toiletries, perfumery, essential oils, pharmaceutical, medical and veterinary preparations, sanitary preparations for medical purposes, dietetic foods and preparations adapted for medical or veterinary use, foodstuffs for infants, dietary supplements for humans and animals, vitamins and vitamin preparations, medical plasters, medical dressings, surgical, medical, and veterinary apparatus and instruments, artificial limbs and eyes, orthopedic articles, suture materials, therapeutic articles and aids adapted for persons with disabilities, massage apparatus, devices and articles for nursing infants, devices and articles for sexual activity; the foregoing excluding dental equipment and other health care products

Publicações

Histórico de despachos e eventos da marca no USPTO.

43 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/03/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

18/02/2026

FIMP

FINAL DISPOSITION PROCESSED

17/02/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/08/2025

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

20/07/2025

CHPB

POST PUBLICATION AMENDMENT - ENTERED

08/07/2025

APET

ASSIGNED TO PETITION STAFF

07/07/2025

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

12/05/2025

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

08/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2025

PUBO

PUBLISHED FOR OPPOSITION

11/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/02/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

09/11/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

23/10/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

23/10/2024

RFNP

REFUSAL PROCESSED BY IB

21/09/2024

CNRT

NON-FINAL ACTION WRITTEN

14/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/07/2024

RFNP

REFUSAL PROCESSED BY IB

27/02/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

31/01/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/01/2024

GNRT

NON-FINAL ACTION E-MAILED

19/01/2024

CNRT

NON-FINAL ACTION WRITTEN

19/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/01/2024

RFNT

REFUSAL PROCESSED BY IB

22/11/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/10/2023

RFRR

REFUSAL PROCESSED BY MPU

30/10/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/10/2023

CNRT

NON-FINAL ACTION WRITTEN

26/10/2023

DOCK

ASSIGNED TO EXAMINER

26/10/2023

MAFR

APPLICATION FILING RECEIPT MAILED

30/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/05/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/05/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ORIFARM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.